Outcomes of Sepsis Patients in China (CHINA-SEP)
ConditionSepsis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSoutheast University, China
About this trial
Sepsis poses a significant public health challenge in China. However, longitudinal real-world evidence on guideline adherence and patient outcomes remains scarce. This registry aims to address these gaps by systematically capturing guideline-concordant treatment patterns and associated outcomes in ICU patients diagnosed according to Sepsis-3.0 criteria across diverse settings, thereby generating actionable evidence to improve the quality of sepsis care nationwide.
Eligibility criteria
Qualifiers
Hospitalized patients aged ≥18 years
Sepsis diagnosis meeting Sepsis-3 criteria
Informed consent signed by patient or legally authorized representative
Disqualifiers
Patients with a prior history of sepsis
Sepsis diagnosis >48 hours prior to enrollment
Current participation in clinical trial
Trial design
Treatments tested in this trial
- Not listed
Trial groups
5,775 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov